High dose steroids (HDS), cyclosporine (CSA) and methotrexate (MTX) versus CSA and MTX as prophylaxis of graft versus host disease (GVHD) in HLA identical bone marrow transplantation (BMT).

被引：0
|
作者：
Macedo, MCMA [1 ]
Pallotta, RS [1 ]
Saboya, R [1 ]
Silva, RL [1 ]
Dzik, C [1 ]
Loterio, H [1 ]
Massumoto, CM [1 ]
Chamone, DAF [1 ]
Dulley, FL [1 ]
机构：
[1] UNIV SAO PAULO,SCH MED,DISCIPLINE HEMATOL,BMT PROGRAM,FUNDACAO PRO SANGUE HEMOCENTRO SAO PAULO,SAO PAULO,BRAZIL
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 417
页数：1
相关论文
共 50 条
  • [21] BONE-MARROW TRANSPLANTATION FROM UNRELATED DONORS USING BUCY4 AND TRIPLE (CSA, MTX AND METHYLPREDNISOLONE) GRAFT-VERSUS-HOST DISEASE IMMUNOPROPHYLAXIS
    FISH, D
    GYGER, M
    BONNY, Y
    ROY, DC
    PERREAULT, C
    KASSIS, J
    BUSQUE, L
    BOILEAU, J
    LAVALLEE, R
    DANGELO, G
    BELANGER, R
    BLOOD, 1994, 84 (10) : A709 - A709
  • [22] Tacrolimus/methotrexate (MTX) versus cyclosprorine/MTX for graft-versus-host disease (GVHD) prophylaxis in patients with severe aplastic anemia (SAA) who received marrow transplantation from unrelated donors: Results of a matched pair analysis
    Kojima, S
    Yabe, H
    Kato, K
    Kigasawa, H
    Sakamaki, H
    Tsuchida, M
    Kato, S
    Morishima, Y
    Kodera, Y
    BLOOD, 2005, 106 (11) : 511A - 511A
  • [23] Results of an audit of a cyclosporin (CSA) sliding scale protocol and it's impact on graft versus host disease (GVHD) related death in allogeneic bone marrow transplantation (BMT)
    Hyde, HL
    BONE MARROW TRANSPLANTATION, 1999, 23 : S268 - S268
  • [24] Relationship between adequate delivery of continous infusion (CIVI) cyclosporine (CSA) and short-course methotrexate (MTX) prophylaxis and the development of severe acute graft-versus-host disease (AGVHD).
    Warkentin, DI
    Nevill, TJ
    Le, A
    Gore, J
    Dossa, A
    Yip, J
    Toze, CL
    Barnett, MJ
    BLOOD, 1998, 92 (10) : 340B - 340B
  • [25] CYCLOSPORINE (CSA) VERSUS CYCLOPHOSPHAMIDE (CY) FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) - EFFECT ON IMMUNE RECONSTITUTION
    DONNENBERG, AD
    HESS, AD
    SANTOS, GW
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 345 - 345
  • [26] Acute graft versus host disease (GVHD), in allogenic bone marrow transplantation (allo-BMT)
    Ghavamzadeh, A
    Shahrasbi, A
    Ghahremani, G
    Khodabandeh, A
    Sedaghat, S
    Najmabad, MH
    BONE MARROW TRANSPLANTATION, 1998, 21 : S120 - S120
  • [27] Cyclosporine A and Mycophenolate Mofetil versus Cyclosporine A and Methotrexate for graft versus host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
    Neumann, F
    Graef, T
    Tapprich, C
    Vaupel, M
    Steidl, U
    Germing, U
    Fenk, R
    Haas, R
    Kobbe, G
    BLOOD, 2004, 104 (11) : 354A - 354A
  • [28] Phase III study comparing tacrolimus (PROGRAF(R), FK506) with cyclosporine for graft-versus-host disease (GVHD) prophylaxis after HLA-identical sibling bone marrow transplantation (BMT).
    Ratanatharathorn, V
    Nash, RA
    Devine, SM
    Przepiorka, D
    Klein, JL
    Weisdorf, DJ
    Fay, JW
    Nademanee, AP
    Antin, JH
    Karanes, C
    Avalos, BR
    Christiansen, NP
    VanderJagt, RH
    Herzig, RH
    Litzow, MR
    Wolff, SN
    Longo, WR
    Petersen, FB
    Buell, DN
    Maher, RM
    Fitzsimmons, WE
    Wingard, JR
    BLOOD, 1996, 88 (10) : 1826 - 1826
  • [29] A randomized double blind trial of T-cell depletion (TCD) with CD5/8 cellector(R) in addition to cyclosporine (CSA), methotrexate (MTX) and steroids for acute graft versus host disease (AGVHD) prevention in HLA mismatched (MM) bone marrrow transplants (BMT).
    Gajewski, J
    Wall, D
    Adkins, D
    Geller, R
    Yver, A
    Lloyd, K
    Souza, S
    Champlin, R
    BLOOD, 1996, 88 (10) : 1002 - 1002
  • [30] ADMINISTRATION OF CYCLOSPORINE TO ORAL, BONE MARROW TRANSPLANTATION AS PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE
    Guarisco, S.
    Bertoni, E.
    Bennato, V
    Soncini, E.
    Notarangelo, L. D.
    Schumacher, F.
    Porta, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S31 - S31
12345